Annick De Loose
Researcher
Also affiliated: University of Arkansas Medical Center (2023); Oxford University Press (United Kingdom) (2020); Winthrop Rockefeller Foundation (2021)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Annick De Loose's research focuses on the application of precision medicine strategies to treat cancer. She has investigated the use of tumor organoid modeling and comparative transcriptomics to identify personalized treatment approaches, particularly for glioblastoma. Her work includes the development of biobanks for brain tumor samples to facilitate precision medicine research. De Loose has also explored therapeutic targets and oncogenic pathways in lymphoma and has contributed to research on the anti-melanoma activity of novel compounds.
Her research publications span areas including functional precision medicine pipelines, biobank development for cancer research, and the identification of therapeutic targets. De Loose has a track record of 68 publications with 135 citations and an h-index of 6. She actively collaborates with researchers at the University of Arkansas for Medical Sciences, including Vijay Patel, Sydnye L. Shuttleworth, Ying-Zhi Xu, and Claire Doshier, with whom she shares 43 co-authored publications.
Metrics
- h-index: 6
- Publications: 68
- Citations: 135
Selected Publications
-
Longitudinal multi-omics characterization of the malignant evolution in multirelapsing glioblastoma (2026)
-
Abstract 2834: Establishment of orthotopic high grade glioma xenograft model using zebrafish embryos (2024)
Collaboration Network
Top Collaborators
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
- Genomic and Transcriptomic Profiling of Brain Metastases
Showing 5 of 7 shared publications
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Genomic and Transcriptomic Profiling of Brain Metastases
- Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Genomic and Transcriptomic Profiling of Brain Metastases
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Genomic and Transcriptomic Profiling of Brain Metastases
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion
- 323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- Genomic and Transcriptomic Profiling of Brain Metastases
- 323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
- Genomic and Transcriptomic Profiling of Brain Metastases
- Synthesis and Anti‐Melanoma Activity of Acryloyl Pyridinone Analogues
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- 323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- 323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- 323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- 323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
- A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
- 323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
- Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
Similar Researchers
Based on overlapping research topics